President Trump, pharmaceutical companies talk drug prices

Feb. 8, 2017
President Donald Trump recently met with pharmaceutical manufacturing companies such as Merck & Co. and Johnson & Johnson to discuss what can be done about the rising cost of drugs. President Trump has recently expressed an interest in allowing the government to negotiate drug prices for programs like Medicare and Medicaid. Additionally, President Trump has indicated that he would support re-importation of drugs. In the meeting, President Trump and the pharmaceutical representatives discussed easing the regulatory burdens on manufacturers and streamlining the drug approval process.